| Schedule of reportable segment |
| | | | | | | | | | | | | | | Three months ended | | Six months ended | | | June 30, | | June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | | | | | | | | | | | | | | Product revenue, net | | $ | 182 | | $ | 120 | | $ | 388 | | $ | 288 | Less: | | | | | | | | | | | | | Cost of goods sold | | $ | 22 | | $ | 107 | | $ | 305 | | $ | 121 | Research and development costs: | | | | | | | | | | | | | Personnel and related costs | | $ | 1,404 | | $ | 1,585 | | $ | 2,869 | | $ | 3,267 | Non-cash stock-based compensation | | | 51 | | | 648 | | | 130 | | | 134 | Professional fees | | | 501 | | | 1,007 | | | 1,043 | | | 1,786 | Clinical trials expense | | | 334 | | | 6,119 | | | 717 | | | 8,137 | Chemical, manufacturing and controls cost | | | 632 | | | 535 | | | 823 | | | 710 | Other expenses | | | 242 | | | 362 | | | 537 | | | 776 | Total research and development costs | | $ | 3,164 | | $ | 10,256 | | $ | 6,119 | | $ | 14,810 | Commercial costs: | | | | | | | | | | | | | Personnel and related costs | | | 78 | | | 84 | | | 156 | | | 163 | Non-cash stock-based compensation | | | — | | | — | | | — | | | - | Professional fees | | | 74 | | | 138 | | | 92 | | | 176 | Commercial and marketing | | | 52 | | | 38 | | | 146 | | | 207 | Travel related expenses | | | 3 | | | 12 | | | 6 | | | 21 | Other expenses | | | 10 | | | (45) | | | 24 | | | (133) | Total commercial costs | | $ | 217 | | $ | 227 | | $ | 424 | | $ | 434 | Selling, general and administrative costs: | | | | | | | | | | | | | Personnel and related costs | | | 1,104 | | | 946 | | $ | 2,160 | | $ | 1,939 | Non-cash stock-based compensation | | | 307 | | | 908 | | | 663 | | | 1,602 | Professional fees | | | 4,794 | | | 2,572 | | | 9,312 | | | 5,406 | Travel related expenses | | | 38 | | | 132 | | | 110 | | | 248 | Other expenses | | | 729 | | | 824 | | | 1,711 | | | 1,679 | Total selling, general and administrative costs | | $ | 6,972 | | $ | 5,382 | | $ | 13,956 | | $ | 10,874 | Total operating expenses | | $ | 10,375 | | $ | 15,972 | | $ | 20,804 | | $ | 26,239 | Other (income) expense | | | | | | | | | | | | | Interest expense | | | 4,257 | | | 4,222 | | | 8,455 | | | 8,215 | Interest income | | | (131) | | | (230) | | | (342) | | | (509) | Other (income) expense, net | | | 394 | | | (657) | | | (1,125) | | | (7,216) | Segment net loss | | $ | (14,713) | | $ | (19,187) | | $ | (27,404) | | $ | (26,441) | Adjustments and reconciling items | | | — | | | — | | | — | | | — | Consolidated Net Loss | | $ | (14,713) | | $ | (19,187) | | $ | (27,404) | | $ | (26,441) |
|